Clinical Report: Frequency of Asymptomatic Meibomian Gland Dysfunction in Adults
Overview
Revise to include the significance of the 72.86% prevalence in the context of existing literature.
Background
Meibomian gland dysfunction is a common ocular surface condition that contributes significantly to dry eye disease. Understanding the prevalence of asymptomatic MGD is crucial, as it may represent early gland abnormalities that can progress to symptomatic conditions. Current reliance on symptom-based assessments may underestimate the true burden of MGD in the population.
Data Highlights
Study Type
Participants
Asymptomatic MGD Cases
Prevalence (%)
Cross-sectional
3,637
1,313
72.86 (95% CI: 19.33–96.78)
Key Findings
The combined prevalence of asymptomatic MGD was found to be 72.86%.
Substantial heterogeneity (I2 = 98.8%) was observed across studies.
Sex distribution significantly contributed to the variability in prevalence estimates.
The overall certainty of the evidence for the pooled prevalence estimate was classified as low.
Asymptomatic MGD may lead to underestimation of the disease burden if only symptomatic assessments are used.
Clinical Implications
Clinicians should consider the high prevalence of asymptomatic MGD when evaluating patients, as it may not present with typical symptoms. Early identification of asymptomatic cases could facilitate preventive strategies to mitigate progression to symptomatic dry eye disease.
Conclusion
Highlight the need for standardized definitions and suggest potential research directions.
More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice
